Related Experiment Video
Updated: Jun 12, 2026

11:23
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description
Maris Lapins1, Jarl Es Wikberg
1Department of Pharmaceutical Pharmacology, Uppsala University, Sweden.
BMC Bioinformatics
|June 24, 2010
Summary
Proteochemometric modeling accurately predicts protein kinase inhibitor interactions, aiding in the design of selective drugs. This approach can accelerate the development of targeted cancer therapies with reduced toxicity.
Area of Science:
- Computational biology
- Drug discovery
- Bioinformatics
Background:
- Protein kinases are vital in cell functions; dysregulation causes diseases like cancer.
- Current kinase inhibitors lack selectivity, leading to toxic side effects.
- Bioinformatics can predict inhibitor-kinase interactions for improved drug design.
Purpose of the Study:
- To develop and validate a proteochemometric model for predicting inhibitor-kinase interactions.
- To identify optimal methods for encoding kinase properties and correlation analysis.
- To assess the model's performance and scalability.
Main Methods:
- Applied proteochemometric modeling to 317 kinases and 38 inhibitors (12,046 combinations).
- Utilized amino acid physico-chemical z-scale descriptors for kinase sequences.
- Employed support vector machines and partial least-squares for correlation analysis.
- Validated models using double cross-validation.
Main Results:
- Achieved high predictive ability for new kinase-inhibitor pairs (P2 = 0.67-0.73) and new kinases (P2kin = 0.65-0.70).
- Demonstrated high sensitivity and specificity in distinguishing interacting pairs (AUC = 0.92-0.93).
- A valid model was obtained using only 10% of the data, showing scalability.
Conclusions:
- Proteochemometrics is highly applicable for kinome-wide interaction modeling.
- This approach can accelerate the identification and optimization of kinase inhibitors.
- Enables the design of more selective kinase-targeted and multi-targeted therapies.
Related Concept Videos
Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

